For 26 years, doctors couldn't diagnose her disease. Then she found the answer—and helped create a cure.

For 26 years, Jasmin Barman-Aksözen suffered inexplicable severe pain when exposed to sunlight—until a discovery she made online finally led to a diagnosis for a rare disease called erythropoietic protoporphyria. In an editorial in Medicine Access @ Point of Care, Barman-Aksözen details how she helped develop the cure to her disease and her battle to get it approved.

Read More
Advisory Board Insight

See the human brain in 'unprecedented detail,' as revealed by Mass Gen. researchers

Researchers at Massachusetts General Hospital in a paper that's awaiting publication say they have produced ultra-high-resolution MRIs of a human brain that represent some of the most detailed three-dimensional images of an intact human brain ever to exist. See the images here.

FDA approves drug to treat antibiotic-resistant TB

FDA on Wednesday approved a new antibiotic, called pretomanid, to treat highly drug-resistant strains of tuberculosis, which kills about 500,000 of the 1.6 million individuals who die annually from the infectious disease.

How med schools are enticing students to rural areas: Whitewater rafting, mayoral visits, and more

To curb a physician shortage in rural areas, a handful of medical schools are offering programs that connect students with rural communities to entice them to practice in these areas, the Associated Press reports.

Around the nation: California hospitals are spending less on charity care since ACA took effect

The hospitals said the decrease in charity care is mostly due to patients gaining coverage through the Affordable Care Act, in today's bite-sized hospital and health industry news from California, Illinois, Iowa, and Massachusetts.

The 10 health care tweets that caught our eye this week

With so many health care providers, thought leaders, journalists, and policymakers active on Twitter, it's easy to miss tweets that are informative, provocative, or entertaining. Here are 10 health care tweets that caught our eyes this week.

Are big employers on board with 'Medicare for All'?

A survey by the National Business Group on Health of 147 large employers that cover more than 15.6 million patients revealed that employers are sharply divided on "Medicare-for-All" proposals—and are planning to implement their own ideas to lower health care costs.

A supposed 'cure' for autism, cancer is actually a 'dangerous bleach,' FDA warns

FDA on Monday warned patients not to drink certain solutions being marketed as cures for autism, cancer, HIV/AIDs, and other diseases and conditions, saying the solutions become a "dangerous bleach" when used as directed.